ask="44.50"
ask_size="100"
average_daily_volume="1132990"
bid="N/A"
bid_size="N/A"
book_value="4.05"
change="+1.16"
change_from_200_day_moving_average="-3.26"
change_from_50_day_moving_average="2.44"
change_from_52_week_high="-11.84"
change_From_52_week_low="12.06"
change_in_percent="+2.75%"
close="43.31"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85794000"
high="43.35"
high_52_weeks="55.15"
last_trade_date="2/3/2017"
last_trade_price="43.31"
last_trade_size="42664"
last_trade_time="4:00pm"
low="41.66"
low_52_weeks="31.25"
market_capitalization="3.76B"
moving_average_200_day="46.57"
moving_average_50_day="40.87"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="42.50"
pe_ratio="N/A"
peg_ratio="0.71"
percent_change_from_200_day_moving_average="-7.00%"
percent_change_from_50_day_moving_average="+5.98%"
percent_change_from_52_week_high="-21.47%"
percent_change_from_52_week_low="+38.59%"
previous_close="42.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.41"
price_per_sales="244.11"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="968494"
weeks_range_52="31.25 - 55.15"
